Bulbicam

DEVICE4 trials

Sponsors

Meddoc

Conditions

Age-Related Macular DegenerationAtaxiaCataractDiabetesDiabetic RetinopathyGlaucoma EyeParkinson Disease

Unknown Phase

Validation of Bulbicam for DR- and AMD-patients

CompletedNCT05441072

MeddocAge-Related Macular Degeneration, Diabetic Retinopathy

Start: 2022-12-19End: 2023-06-15Updated: 2024-05-22

Bulbicam Validation on Glaucoma- and Cataract Patients

CompletedNCT05449041

MeddocCataract, Glaucoma Eye

Start: 2023-01-10End: 2023-05-31Updated: 2024-05-22

Validation of Bulbicam for Parkinson- and Ataxia-patients

CompletedNCT05680571

MeddocAtaxia, Parkinson Disease

Start: 2022-12-19End: 2023-03-30Updated: 2024-05-22

Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy

CompletedNCT06973694

Start: 2024-06-03End: 2025-04-16Updated: 2025-05-15

Related Papers

Eye-tracking biomarkers for glaucoma based on saccadic reaction time: a controlled clinical study.

2025-10-161 citations